Diagnoly

Diagnoly is an innovative DeepTech startup that addresses a critical pain-point in obstetric ultrasound. It's estimated that nearly 50% of fetal pathologies remain undetected during prenatal screening, affecting all stakeholders (babies, doctors and the healthcare system).

To address this problem, we have developed an AI-powered medical device that seamlessly integrates with all ultrasound systems. By analyzing fetal ultrasound stream in real-time, our technology both accelerates and secures fetal examination while significantly improving the detection rate of fetal pathologies.

By developing our signature technology for the fetal heart, we have made the fetal examination significantly user-independent, positioning Diagnoly as the first and only company today able to handle this most complex and impactful organ. Based on this achievement, we are currently extending our expertise to other fetal organs.